维姆塞尔蒂尼布与安慰剂对抗瘤巨细胞 (MOTION):多中心,随机,双盲,安慰剂对照的第三期试验
Hans Gelderblom1, Vivek Bhadri2, Silvia Stacchiotti3
1Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands.
Lancet (London, England)
|June 6, 2024
概括
维姆塞尔蒂尼布显著改善了前列腺巨细胞瘤 (TGCT) 患者的结果. 这项研究显示,使用维姆塞尔提尼布的客观反应率为40%,为这种罕见疾病提供了新的治疗选择.
科学领域:
- 癌症学
- 药理学
背景情况:
- 长巨细胞瘤 (TGCT) 是一种罕见的局部侵袭性瘤,全身治疗选择有限.
- 目前用于TGCT的治疗方法往往具有显著的副作用或有限的疗效,因此需要新的治疗方法.
研究的目的:
- 评估Vimseltinib (一种CSF1R抑制剂) 在症状TGCT患者中的疗效和安全性.
- 在第三阶段临床试验中确定维姆塞尔提尼的客观反应率 (ORR) 和安全性.
主要方法:
- MOTION试验是一项3期,随机,双盲,安慰剂对照试验,涉及123名TGCT患者.
- 患者接受了维姆塞尔蒂尼布 (30毫克每周两次) 或安慰剂24周,主要终点是RECIST标准的ORR在第25周.
主要成果:
- 与安慰剂组的0%相比,Vimseltinib的客观反应率为40% (p< 0. 0001).
- 大多数与治疗相关的不良事件是低级的,最常见的3/4级事件是肌酸基酶的增加.
- 没有发现显著的肝毒性.
结论:
- 维姆塞尔蒂尼布为TGCT患者提供了显著和有效的治疗选择,显示出显著的客观反应.
- 该药物提供了临床上有意义的功能和症状改善,解决了TGCT管理中的未满足需求.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
05:29A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
2.8K
相关概念视频
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
